![We Care for Every Heartbeat]({"type":"image" , "src" : "/sda/112416/JournalAd-TACD-Daiichi.jpg"})
References
- Kramsch DM. Limits of lipid-lowering therapy: the poten-tial benefits of amlodipine as an antiathero sclerotic agent. Int J Cardiol 1997; 62: S119–24.
- Maxwell SR. Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine. Basic Res Cardiol 2000; 95 suppl 1: 165–71.
- Tulenko TN, Sumner AE, Chen M, Huang Y, Laury-Kleintop L, Ferdinand FD. The smooth muscle cell mem-brane during atherogenesis: a potential target for amlodip-ine in atheroprotection. Am Heart J2001; 141:S1–11.
- Beutler E. Red cell metabolism. A manual of biomedical methods. Grune and Stratton Inc, Orlando; 1984: 72–3.
- Carmagnol F, Smet PM, Rapin J, Jerome H. Glutathione-S-transferase of human red blood cells; assay, values in normal subjects and in two pathological circumstances: hyperbilirubinemia and impaired renal function. Clin Chim Acta 1981; 117: 209–17.
- Beckett GJ, Hayes JD. Glutathione-S-transferase: biomedical applications. Adv Clin Chem 1993; 30: 282–359.
- Eickelberg O, Roth M, Block LH. Effects of amlodipine on gene expression and extracellular matrix formation in human smooth muscle cells and fibroblasts: implications for vascu-lar protection. Int J Cardiol 1997; 62: S31–7.
- Asanuma H, Kitakaze M, Funaya H, Takashima S, Minamino T, Node K, Sakata Y, Asakura M, Sanada S, Shinozaki Y, Mori H, Kuzuya T, Tada M, Hon M. Nifedip-ine limits infarct size via NO-dependent mechanisms in dogs. Basic Res Cardiol 2001; 96: 497–505.
- Clarkson P, Mullen MJ, Donald AE, Powe AJ, Thomson H, Thorne SA, Bull T, Deanfield JE. The effect of amlodip-ine on endothelial function in young adults with a strong family history of premature coronary artery disease: a ran-domized, double blind study. Atherosclerosis 2001; 154: 171–7.
- Mason RP, Mak T, Trumbore Mark W, Mason PE. Antiox-idant properties of calcium antagonists related to mem-brane biophysical interactions. Am J Cardiol 1999; 84: 16L–22L.
- Schatcher M. Calcium antagonists and atherosclerosis. Int J Cardiol 1997; 62: S9–15.
- Kirschenbaum MA, Roh DD, Komanna VS. Effect of nifedipine on renal microvascular cholesterol accumulation and prostacyclin biosyntesis in cholesterol-fed rabbits. Ath-erosclerosis 1991; 91: 241–6.
- Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Granjean P. Plasma malondialdehyde as a biomarker for oxidative stress: reference intervals and effects of life-style factors. Clin Chem 1997; 43: 1209–14.
- Beutler E. Red cell metabolism. A manual of biomedical methods. Grune and Stratton Inc. Orlando: 1984; 74–6.
- Beutler E. Red cell metabolism. A manual of biomedical methods. Grune and Stratton Inc Orlando; 1984: 134–5.
- Teare JP, Punchard NA, Powell JJ, Lumb PJ, Mitchell WD, Thompson RPH. Automated spectrophotometric method for determining oxidized and reduced glutathione. Clin Chem 1993; 39: 686–9.
- Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione per-oxidase. J Lab Clin Med 1967; 70: 158–69.
- Habig WH, Pabst MJ, Jacoby WB. Glutathione S-trans-ferase. The first enzymatic step in mercapturic acid forma-tion. J Biol Chem 1974; 249: 7130–9.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75.
- Bocan TM. Animal models of atherosclerosis and interpre-tation of drug intervention studies. Curr Pharm Des 1998; 4: 37–52.
- Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of atherosclerotic effects of vit-amin E, lovastatin and amlodipine. J Am Coll Cardiol 1997; 30: 569–75.
- Hayashi T, Yamada K, Esaki T, Kano H, Asai Y, Kumar Thakur N, Jayachandran M, Sumi D, Iguchi A. Endothe-lium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia; possible role of peroxynitrite. Atherosclerosis 1999; 147: 349–63.
- Kouzuma R, Tasaki H, Komura T, Nakashima Y, Kuroiwa A, Tanimoto A, Koide O. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by cholesterol diet in rabbit aorta. Artery 1995; 21: 337–51.
- Hoshida S, Yamashita N, Kuzuya T, Hon M. Reduction in infarct size by chronic amlodipine treatment in cholesterol-fed rabbits. Atherosclerosis 1998; 138: 163–70.
- De La Cruz JP, Qintero L, Villalobos A, De La Cuesta FS. Lipid peroxidation and glutathione system in hyperlipemic rabbits: influence of olive oil administration. Biochim Bio-phys Acta 2000; 1485: 36–44.
- Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Bohm M, Meinertz T, Munzel T. Increased NADH-oxidase-mediated superoxide productions in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999; 99: 2027–33.
- Toborek M, Kaiser S. Endothelial cell functions. Relation-ship to atherogenesis. Basic Res Cardiol 1999; 94: 295–314.
- Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546.
- Turgan N, Habif S, Kabaroglu CG, Mutaf I, Ozmen D, Bayindir 0, Uysal A. Effects of calcium channel blocker amlodipine on serum and aorta cholesterol, lipid peroxida-tion, antioxidant status and aortic histology in cholesterol-fed rabbits. J Biomed Sci 2003; 10: 65–72.
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.]({"type":"image" , "src" : "/sda/112392/Skyscraper_BristolMyersSquibb.jpg"})